Patenting for Impact: How IP Transforms Gene Therapy Research into Patient Solutions #14 - with Prof. Els Henckaerts

Els Henckaerts, MD, PhD is the head of the Laboratory of Viral Cell Biology and Therapeutics at KU Leuven. In this interview with Els, we see her as a researcher, as the CSO of a recently stablished spin-off and as a professor and mentor. We learned about the advances of gene therapy, the importance of having the right support and strong patents when creating a spin-off, the relationship between the academic research and the pharma industry, and the amazing feeling she gets from seeing her PhD students thrive and collaborate with them.   This episode is part of a tech transfer special, a series of interviews to better understand the transfer of knowledge from research centres, universities and laboratories, to the industry and our lives. Check Henckaertslab website here: https://henckaertslab.org/